期刊
INTERNATIONAL IMMUNOLOGY
卷 21, 期 1, 页码 53-62出版社
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxn123
关键词
-
类别
资金
- Spanish Ministry of Education and Science [SAF03/05184, SAF06/03687]
- Spanish Ministry of Health [FIS PI061320]
- Junta de Extremadura, Spain [03/2, 3PR05A012]
- European Regional Development Fund (FEDER)
- Outcome and Impact of Specific Treatment in European Research on Melanoma [QLRT-2001-00668]
- 5th Framework Program of the European Union [QLK6-CT2002-02283]
- 6th FP European Network [503306]
- AIDS Research and Reference Reagent Program
- NIAID
- NIH
- Maurice Gately, Hoffmann-La Roche Inc
Adoptive transfer of antigen-specific CD8(+) T cells may represent an effective strategy for immunotherapy of tumors such as melanoma, but is limited by the number and functionality of in vitro expanded T cells. Here, we document that although ELAGIGILTV-specific CD8(+) T cells from different donors initially possessed a naive phenotype, after antigen-induced in vitro expansion two distinct phenotypes correlating with cell proliferation rate emerged in the different donors. Those cultures achieving fewer cumulative population doublings (CPDs) were cytotoxic and displayed a CD45RA(+)CCR7(-) phenotype. In contrast, cultures reaching higher CPDs were non-cytotoxic T cells with a CD45RA(-)CCR7(-) phenotype. Thus, the generation of larger numbers of ELAGIGILTV-specific CD8(+) T cells correlates negatively with the acquisition of a CD45RA(+)CCR7(-) phenotype and cytotoxic capacity. A better understanding of the differentiation pathways of cytotoxic T cells to obtain optimally efficient cells for adoptive transfer will allow the development of new immunotherapy protocols.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据